With federal authorities trying to chill private equity investment in healthcare, firms need strategies for clearing government reviews, according to an antitrust attorney who has helped fend off challenges to mergers.

For private equity firms, dark clouds hang over the US healthcare sector. The Biden administration recently began investigating private equity profiteering in medicine. Antitrust authorities released new rules letting them block more private equity healthcare deals, and many states have followed suit. Following the recent bankruptcy of hospital operator Steward Health Care System, lawmakers have promised further action.